DK1485483T3 - Proteolyseresistent aktivt VEGF - Google Patents

Proteolyseresistent aktivt VEGF

Info

Publication number: DK1485483T3
Authority: DK; Denmark
Prior art keywords: vegf; nucleic acids; resistant active; active vegf; proteolysis resistant
Prior art date: 2002-03-08

Application number

DK03720320T

Other languages

Danish (da)

English (en)

Inventor

Sabine Eming

Thomas Krieg

Stephan Sollberg

Gereon Lauer

Original Assignee

Bayer Innovation Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-08

Filing date

2003-03-06

Publication date

2009-01-05

2003-03-06 Application filed by Bayer Innovation Gmbh filed Critical Bayer Innovation Gmbh

2009-01-05 Application granted granted Critical

2009-01-05 Publication of DK1485483T3 publication Critical patent/DK1485483T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

DK03720320T 2002-03-08 2003-03-06 Proteolyseresistent aktivt VEGF DK1485483T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02005186A EP1342783A1 (fr)	2002-03-08	2002-03-08	VEGF actif et résistant au protéolyse
PCT/EP2003/002289 WO2003076625A1 (fr)	2002-03-08	2003-03-06	Facteur de croissance vegf actif et resistant a la proteolyse

Publications (1)

Publication Number	Publication Date
DK1485483T3 true DK1485483T3 (da)	2009-01-05

Family

ID=27741149

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03720320T DK1485483T3 (da)	2002-03-08	2003-03-06	Proteolyseresistent aktivt VEGF

Country Status (10)

Country	Link
US (3)	US7491696B2 (fr)
EP (2)	EP1342783A1 (fr)
AT (1)	ATE409230T1 (fr)
AU (1)	AU2003223956A1 (fr)
CA (1)	CA2518248A1 (fr)
DE (1)	DE50310541D1 (fr)
DK (1)	DK1485483T3 (fr)
ES (1)	ES2312767T3 (fr)
PT (1)	PT1485483E (fr)
WO (1)	WO2003076625A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105646697B (zh) *	2016-04-08	2019-03-19	新乡医学院	VEGF165b突变体及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5219739A (en) *	1989-07-27	1993-06-15	Scios Nova Inc.	DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US6020473A (en) *	1995-08-25	2000-02-01	Genentech, Inc.	Nucleic acids encoding variants of vascular endothelial cell growth factor

2002
- 2002-03-08 EP EP02005186A patent/EP1342783A1/fr not_active Withdrawn
2003
- 2003-03-06 EP EP03720320A patent/EP1485483B1/fr not_active Expired - Lifetime
- 2003-03-06 DK DK03720320T patent/DK1485483T3/da active
- 2003-03-06 US US10/506,893 patent/US7491696B2/en not_active Expired - Fee Related
- 2003-03-06 AU AU2003223956A patent/AU2003223956A1/en not_active Abandoned
- 2003-03-06 ES ES03720320T patent/ES2312767T3/es not_active Expired - Lifetime
- 2003-03-06 CA CA002518248A patent/CA2518248A1/fr not_active Abandoned
- 2003-03-06 WO PCT/EP2003/002289 patent/WO2003076625A1/fr active IP Right Grant
- 2003-03-06 DE DE50310541T patent/DE50310541D1/de not_active Expired - Lifetime
- 2003-03-06 AT AT03720320T patent/ATE409230T1/de active
- 2003-03-06 PT PT03720320T patent/PT1485483E/pt unknown
2009
- 2009-01-07 US US12/349,531 patent/US8168590B2/en not_active Expired - Fee Related
2012
- 2012-04-12 US US13/445,016 patent/US20120258915A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US8168590B2 (en)	2012-05-01
EP1485483A1 (fr)	2004-12-15
ATE409230T1 (de)	2008-10-15
PT1485483E (pt)	2008-12-03
CA2518248A1 (fr)	2003-09-18
DE50310541D1 (de)	2008-11-06
ES2312767T3 (es)	2009-03-01
US7491696B2 (en)	2009-02-17
US20110009316A1 (en)	2011-01-13
EP1485483B1 (fr)	2008-09-24
US20060148687A1 (en)	2006-07-06
AU2003223956A1 (en)	2003-09-22
EP1342783A1 (fr)	2003-09-10
WO2003076625A1 (fr)	2003-09-18
US20120258915A1 (en)	2012-10-11

Similar Documents

Publication	Publication Date	Title
ITTO20011228A0 (it)	2001-12-28	Contenitore per ago monouso.
ATE462006T1 (de)	2010-04-15	Isoform des vegfs
DE60111570D1 (de)	2005-07-21	Isoindolin-1-on als glukokinaseaktivatoren
MXPA02010787A (es)	2003-07-14	Peptidos modificados como agentes terapeuticos.
DE60233955D1 (de)	2009-11-19	Spezifische bindungsmittel von human angiopoietin-2
YU9404A (sh)	2006-08-17	Multimerna, usmerena kontrastna sredstva na bazi peptida
CY1110547T1 (el)	2015-04-29	Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους
BR0202290B1 (pt)	2012-03-20	ôaparato de moldagemö.
DE69907137T2 (de)	2003-11-27	Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
CY1112957T1 (el)	2016-04-13	Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου
DE50207315D1 (de)	2006-08-03	Verschlusskappe für infusions- oder transfusionsflaschen
ATE330017T1 (de)	2006-07-15	Kallikrein gen
DE60200078D1 (de)	2003-12-11	Infusionsbehälter
ATE323722T1 (de)	2006-05-15	Antimikrobiell wirkendes peptid
AR047756A1 (es)	2006-02-22	Composicion liquida biologicamente estable de fviii, de fvw o del complejo fviii/fvw humanos
DK1485483T3 (da)	2009-01-05	Proteolyseresistent aktivt VEGF
DK1343896T3 (da)	2007-04-10	Lille syreoplöseligt sporeprotein og anvendelser deraf
FI20011550A0 (fi)	2001-07-16	Polypeptidien immobilisointimenetelmä
DK1390364T3 (da)	2004-12-20	Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
MXPA04004304A (es)	2004-08-11	Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.
ITTO20020743A1 (it)	2003-02-24	Procedimento per la lavorazione di uno stampo in resina.
ES1048112Y (es)	2001-11-01	Recipiente refrigerado.
IT1317507B1 (it)	2003-07-09	Dispositivo per l'applicazione di cravatte, particolarmente perfacilitare la realizzazione del nodo della cravatta.
IT1299188B1 (it)	2000-02-29	Plasmide per la produzione di peptidi antimicrobici in batteri ricombinanti.
MXPA04004303A (es)	2004-08-11	Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos pai-1.